Wampole Natural Ointment
Natural health product licensed in Canada
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 80032942
- Status
- Active licence
- Licence date
- 19 June 2012
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Extrait de Boswellia Serrata, Cire d'abeille, Huile de graines d'Helianthus Annus (tournesol), Extrait de feuilles d'Aloe barbadensis, Eau purifiée, Paraffine liquide, Extrait floral de Lavandula Angustifolia (Lavande), Extrait de Butyrospermum Parkii(Beurre de Karatité), Huile de coco fractionnée, Melaleuca alternifolia leaf oil
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Dries the oozing and weeping and helps relieve minor skin irritation due to poison ivy, poison oak and poison sumac.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80032942
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.